TURS During Transurethral Vaporization of the Prostate ( Report of 19 Cases)

杨堃,张峰,刘思宽,江鱼

DOI: https://doi.org/10.3760/j:issn:1000-6702.2004.02.014

2004-01-01

Abstract:Objective To summerize the therapeutic ex pe rience of TURS during transurethral vaporization of the prostate (TUVP). Methods Among the consecutive 213 patients who underwent TUVP from February 1998 to February 2003,using vaporization electrode and vapori-res ection electrode,none had significant TURS,but 19 men (8.9%) had serum sodium le vels125 mmol/L at the end of operation.The data of operation,monitor,clinical t est of the 19 men were reviewed retrospectively. Results Of the 19 patients,mean operative time was 79 minutes,average blood loss was 1 56 ml,the prostatic capsule was perforated in 4 cases (21%),the resected BPH tis sue weighed 20.7 g in average.At the end of the operation,the serum sodium and h emoglobin levels declined (15.8±5.8)mmol/L( P 0.001) and (16±8.5)g/L( P 0.01) respectively,whereas the hematocrit declined (3.68±8.30)% ( P 0.05).11 cases (57.9%) had no symptoms (abnormal CVP in 2 cases). 8 cases (42.1%) had on e or several transient ( 5 minutes) symtoms,included vomiting,fidgeting,bradyca rdia,hypotension,chills,etc (abnormal CVP in 7 cases). Conclusions Although TUVP can decrease fluid absorption, the risk of TURS present still,especially the operation time prolonged,prostatic capsule perforated,bloo d loss increased.Keep close watch over CVP,serum sodium level and patient’s sig ns,TURS be could avoid.